Australia's notifiable diseases status, 2000: Annual report of the National Notifiable Diseases Surveillance System

The Australia’s notifiable diseases status 2000 report provides data and an analysis of communicable disease incidence in Australia during 2000. This section of the annual report contains the appendices. The full report can be viewed in 23 HTML documents and is also available in PDF format. The 2000 annual report was published in Communicable Diseases Intelligence Vol 26 No 2, June 2002.

Page last updated: 10 July 2002

A print friendly PDF version is available from this Communicable Diseases Intelligence issue's table of contents.


Appendix

All definitions from Surveillance Case Definitions, National Health and Medical Research Council, March 1994, except those marked * which are draft summary definitions from the Communicable Diseases Network Australia (January 2001). Some Australian States and Territories have their own case definitions for some diseases, which may vary from those shown here.

Appendix 1a. Case definitions and mapping to ICD-10 code for notifiable diseases reported to NNDSS in 2000, bloodborne diseases

Disease
Case definition (NHMRC 1994)
ICD-10 code(s)
Hepatitis B (incident) Demonstration of documented seroconversion to hepatitis B B16
Hepatitis B (unspecified) HBsAg positive
AND
either: anti-HBcIgM positive
or demonstration of a clinical illness consistent with acute viral hepatitis (jaundice, elevated aminotransferases)
B18.0, B18.1
Hepatitis C (incident) Demonstration of documented seroconversion to hepatitis C B17.1
Hepatitis C (unspecified) Demonstration of anti-hepatitis C positive or hepatitis C PCR positive
AND
a clinical illness consistent with acute viral hepatitis
AND
is not an acute case of hepatitis A, B, or D
B18.2
Hepatitis D* Positive for anti-hepatitis D virus (HDV) or HDV Ag or seroconversion or rise in IgG in serum or liver
AND
HBsAg
OR
anti-HBc negative
B17.0, B16.1, B18.0
Hepatitis (NEC) Any other viral hepatitis not classified here B17.8


Appendix 1b. Case definitions and mapping to ICD-10 code for notifiable diseases reported to NNDSS in 2000, gastrointestinal diseases

Disease
Case definition (NHMRC 1994)
ICD-10 code(s)
Botulism A clinically compatible illness (diplopia, blurred vision, muscle weakness, paralysis or bulbar palsy) with a history of exposure to a probable food source in the absence of a contaminated wound
AND
one of the following: isolation of Clostridium botulinum from faeces or other clinical specimens,
or detection of C. botulinum toxin in serum, faeces or probable food source,
or epidemiological linkage to other cases of confirmed foodborne botulism
AO5.1
Campylobacteriosis Isolation of Campylobacter species from a clinical specimen AO4.5
Haemolytic uraemic syndrome Acute microangiopathic anaemia on peripheral blood smear
AND
acute renal impairment
AND/OR
thrombocytopaenia
D59.3
Hepatitis A Anti-HAV IgM positive in the absence of recent vaccination
OR
demonstration of a clinical case of hepatitis (jaundice and/or elevated aminotransferase levels) without a non-infectious cause
B15
Hepatitis E* A person who demonstrates anti-HEV IgM in sera collected less than 4 weeks after onset of acute hepatitis
OR
IgG seroconversion in paired sera
OR
HEV identified by nucleic acid test
OR
HEV identified by electron microscopy on stool
OR
a hepatitis-like illness in the absence of other causes of hepatitis and detection of antibodies to HEV
B17.2
Listeriosis Isolation of Listeria monocytogenes from a site which is normally sterile, including foetal gastrointestinal contents A32
Salmonellosis Isolation of Salmonella species (excluding S. Typhi ) from any clinical specimen AO2
Shigellosis Isolation of Shigella species from any clinical specimen AO3
SLTEC, VTEC* A person with bloody diarrhoea or HUS from whom in a clinical specimen: Shiga-toxin producing E. coli are isolated
OR
isolation of Shiga toxin from an E. coli isolate
OR
identification of the gene associated with the production of Shiga toxin in E. coli
A4.1, A4.4
Typhoid Isolation of Salmonella Typhi or S. Paratyphi serotype A, B, or C from any clinical specimen AO1.0
Yersiniosis Isolation of Yersinia enterocolitica or Y. pseudotuberculosis from blood or faeces
OR
detection of circulating antigen by ELISA or agglutination test
OR
positive Yersinia serology in the presence of clinical compatible illness
AO4.6


Top of pageAppendix 1c. Case definitions and mapping to ICD-10 code for notifiable diseases reported to NNDSS in 2000, quarantinable diseases

Disease
Case definition (NHMRC 1994)
ICD-10 code(s)
Cholera An illness characterised by diarrhoea and/or vomiting
AND isolation of toxigenic Vibrio cholerae serogroup O1 or O139 from a clinical sample
AO0
Plague A fourfold or greater change in serum antibody titre for Yersinia pestis
OR isolation of Yersinia pestis from a clinical specimen
A20
Rabies Clinically compatible neurological illness
AND either detection of viral antigens in tissue
or isolation of rabies virus from saliva, skin snips, CSF or neural tissue
A82
Viral haemorrhagic fever Sudden or insidious onset of fever, nausea, vomiting, diarrhoea, multifocal haemorrhages and shock. An appropriate travel history to an endemic country is supportive of diagnosis
AND one of the following: demonstration of specific IgM antibody by ELISA, IFA or Western blot
or isolation of the virus in cell culture
or demonstration of viral antigen in a tissue specimen to Ebola virus, Lassa fever virus, Marburg virus or Crimean Congo virus.
A96, A98, A99
Yellow fever A clinically compatible illness
AND demonstration of yellow fever virus, antigen or genome in any clinical specimen
OR a fourfold or greater change in serum antibody titre to yellow fever virus,
OR a single elevated yellow fever specific IgM antibody titre, where cross-reaction with other flaviviruses has been ruled out and the patient has not received yellow fever vaccine during the previous 2 months
A95


Appendix 1d. Case definitions and mapping to ICD-10 code for notifiable diseases reported to NNDSS in 2000, sexually transmissible infections

Disease
Case definition (NHMRC 1994)
ICD-10 code(s)
Chancroid Isolation of Haemophilus ducreyi from a clinical specimen
OR
a clinically compatible illness characterised by painful genital ulceration and inflammatory inguinal adenopathy, where syphilis, granuloma inguinale and herpes simplex have been excluded
OR
a clinically compatible illness in a patient who is epidemiologically linked to a laboratory confirmed case
A57
Chlamydial infection Isolation of Chlamydia trachomatis from a clinical (genital) specimen
OR
demonstration of Chlamydia trachomatis in a clinical (genital) specimen by antigen detection methods
A56
Donovanosis Demonstration of intracytoplasmic Donovan bodies on Wright or Giemsa stained smears or biopsies of clinical specimens
OR
a clinically compatible illness characterised by usually painless, beefy red, granulomatous or ulcerative lesions with rolled edges and a tendency to form scar tissue, where syphilis has been excluded
A58
Gonococcal infection Isolation of Neisseria gonorrhoeae from a clinical specimen A54
Lymphogranuloma venereum Isolation of Chlamydia trachomatis serotypeL1, L2 or L3 from a clinical specimen
OR
demonstration (by immunofluorescence) of inclusion bodies in leucocytes aspirated from an inguinal lymph node (bubo)
OR
a positive serological test for lymphogranuloma venereum strain of Chlamydia trachomatis in the presence of a clinically compatible illness (one or more tender, fluctuant inguinal lymph nodes or characteristic proctogenital lesions)
A55
Syphilis A compatible clinical illness or past history
AND
demonstration of Treponema pallidum by darkfield, fluorescent antibody or equivalent microscopic methods
OR
reactive treponemal tests (e.g.: FTA-ABS, TPHA)
A50, A51, A52


Top of pageAppendix 1e. Case definitions and mapping to ICD-10 code for notifiable diseases reported to NNDSS in 2000, vaccine preventable diseases

Disease
Case definition (NHMRC 1994)
ICD-10 code(s)
Diphtheria Isolation of toxigenic Corynebacterium diphtheriae
AND
pharyngitis and/or laryngitis (with or without a membrane
OR
toxic (cardiac or neurological) symptoms
A36
Haemophilus influenzae type B An invasive clinically compatible illness (meningitis, epiglottitis, cellulitis, septic arthritis, osteomyelitis, pneumonia, pericarditis or septicaemia)
AND
either the isolation of Haemophilus influenzae type b (Hib) from blood
or detection of Hib antigen (in a clinical case)
or detection of Gram-negative bacteria where the organism fails to grow in a clinical case
A41.3, GO0.0, JO5.1
Measles An illness characterised by all the following features: a generalised maculopapular rash lasting three or more days
AND
a fever (at least 38oC)
AND
cough or coryza or conjunctivitis or Koplik spots
OR
Demonstration of measles specific IgM antibody
OR
A fourfold or greater change in measles antibody titre between acute and convalescent-phase sera obtained at least 2 weeks apart, with tests preferably conducted at the same laboratory
OR
Isolation of the measles virus from a clinical specimen
OR
A clinically compatible case epidemiologically related to another case
BO5
Mumps Isolation of mumps virus from a clinical specimen
OR
significant rise in mumps antibody level by any standard serological assay, except following immunisation
OR
a clinically compatible illness (unilateral or bilateral swelling of the parotid or other salivary glands lasting 2 days or more without other apparent cause)
B26
Pertussis Isolation of Bordetella pertussis from a clinical specimen
OR
elevated Bordetella pertussis-specific IgA in serum or B. pertussis antigen in a nasopharyngeal specimen using immunofluorescence with a history of clinically compatible illness
A37
Poliomyelitis Acute onset of a flaccid paralysis of one or more limbs with decreased or absent tendon reflexes in the affected limbs without other apparent cause, without sensory or cognitive loss A80
Rubella A generalised maculopapular rash and fever
AND
one or more of: arthralgia/arthritis
or lymphadenopathy
or conjunctivitis
AND
an epidemiological link to a confirmed case
OR
demonstration of rubella-specific IgM antibody, except following immunisation
OR
a fourfold or greater change in rubella antibody titre between acute and convalescent-phase sera obtained at least 2 weeks apart
BO6
Tetanus A clinically compatible illness without other apparent cause, with or without a history of injury and with or without laboratory evidence of the organism or its toxin A33


Appendix 1f. Case definitions and mapping to ICD-10 code for notifiable diseases reported to NNDSS in 2000, vectorborne diseases

Disease
Case definition (NHMRC 1994)
ICD-10 code(s)
Arbovirus infection (NEC) Demonstration of a fourfold or greater change in serum antibody titres between acute and convalescent-phase serum specimens obtained at least 2 weeks apart and preferable, conducted at the same laboratory
OR
demonstration of specific IgM antibodies in CSF or acute phase serum
OR
isolation of virus from blood, CSF or tissue specimens
A92, A93, A94
Barmah Forest virus infection Demonstration of above criteria for Barmah Forest virus A92.8
Ross River virus infection Demonstration of criteria above for Arbovirus infection for Ross River virus B33.1
Dengue Demonstration of above criteria for dengue virus (all types) A90
Malaria Demonstration of malaria parasites (Plasmodium species) in a blood film B50, B51, B52, B53


Top of pageAppendix 1g. Case definitions and mapping to ICD-10 code for notifiable diseases reported to NNDSS in 2000, zoonoses

Disease
Case definition (NHMRC 1994)
ICD-10 code(s)
Brucellosis Isolation of Brucella species from a clinical specimen
OR
a fourfold or greater change in Brucella agglutination titres or complement-fixation titres between acute and convalescent-phase serum samples at least 2 weeks apart with the tests preferably conducted at the same laboratory
A23
Hydatid infection Positive serological test for infection with Echinococcus granulosus in a patient with clinical, radiological or sonographic evidence of hydatid disease
OR
identification of Echinococcus granulosus in cyst fluid or sputum
OR
immunoelectrophoresis demonstrating arc 5 or three or more arcs
A28
Leptospirosis Isolation of Leptospira species from clinical specimens
OR
a fourfold or greater change in Leptospira agglutination titres or complement-fixation titres between acute and convalescent-phase serum samples at least 2 weeks apart with the tests preferably conducted at the same laboratory
OR
demonstration of leptospiral antigen in a clinical specimen
OR
a single raised Leptospira agglutination titre with a clinically compatible illness
A27
Ornithosis (psittacosis)* A clinically compatible illness (fever, headache, myalgia, dry cough, pneumonia)
AND
a fourfold or greater rise in serum antibody titres to Chlamydia psittaci between acute and convalescent phase sera
OR
detection of C. psittaci by nucleic acid test
OR
a single high titre of IgG to C psittaci after the onset of a clinically compatible illness and where other diseases are excluded
A70
Q fever A fourfold or greater change in serum (CF) antibody titre to phase II antigen of Coxiella burnetii
OR
a fourfold or greater change in ELISA antibody titre to phase I or II antigens of C. burnetii
OR
an IgM fluorescent antibody titre of at least 1:160 during convalescent phase of the illness (i.e.: 10 days or more after onset)
A78


Appendix 1h. Case definitions and mapping to ICD-10 code for notifiable diseases reported to NNDSS in 2000, other bacterial infections

Disease
Case definition (NHMRC 1994)
ICD-10 code(s)
Legionellosis A clinically compatible illness (fever, cough or pneumonia)
AND
at least one of the following: isolation of Legionella species from lung tissues, respiratory secretions, pleural fluid, blood or other tissues
OR
demonstration of Legionella species antigens in lung tissue, respiratory secretions or pleural fluid
OR
a fourfold or greater rise in (IFA) titre against Legionella species to at least 128, between acute and convalescent phase sera
OR
a stable high Legionella titre (at least 512) in convalescent phase serum
A48.1
Leprosy Enlarged dermal nerves with associated sensory loss
OR
demonstration of acid-fast bacilli or biopsy specimen
OR
a histological picture compatible with leprosy in a specimen
A30
Meningococcal infection Isolation of Neisseria meningitidis from a normally sterile site
OR
detection of meningococcal antigen in joints, blood or CSF
OR
detection of Gram-negative intracellular diplococci in blood or CSF
A39
Tuberculosis Isolation of Mycobacterium tuberculosis, Mycobacterium bovis, or Mycobacterium africanum from a clinical specimen
OR
demonstration of acid-fast bacilli in a clinical specimen or in a histopathological lesion, when culture is not available, in a person with signs or symptoms compatible with tuberculosis
OR
evidence of resolution of disease where treatment with two or more anti-tuberculosis medications have been prescribed and follow-up has been instigated
A15, A16, A17, A18, A19


Top of pageAppendix 2. Completeness of National Notifiable Diseases Surveillance System data received from States and Territories, 2000

Field
ACT NSW NT Qld SA Tas Vic WA Aust
No. missing age
0
12
51
0
107
8
150
12
340
% complete for age
100.0
100.0
98.5
100.0
98.3
99.5
99.3
99.9
99.6
No. missing sex
3
64
13
3
1
6
307
23
420
% complete for sex
99.8
99.7
99.6
100.0
100.0
99.6
98.5
99.8
99.5
No. missing Indigenous status
567
16,727
331
18,829
966
1,251
18,669
3,896
61,236
% complete for indigenous status
56.7
31.2
90.5
9.3
84.8
23.6
9.1
65.8
31.8


Appendix 3. Population totals for States and Territories, 2000*

ACT NSW NT Qld SA Tas Vic WA Aust
314,036
6,463,455
195,463
3,566,357
1,497,634
470,376
4,765,856
1,883,860
19,157,037

* Based on Australian Bureau of Statistics mid-year population estimates


This article was published in Communicable Diseases Intelligence Volume 26, No 2, June 2002

Communicable Diseases Intelligence subscriptions

Sign-up to email updates: Subscribe Now